UBA1 and acute myeloid leukemia: Recently, in acute myeloid leukemia, BEND3 is identified as a key gene whose deletion results in resistance to TAK-243, a first-in-class inhibitor of ubiquitin-like modifier activating enzyme 1, via regulating breast cancer resistance protein (BCRP)63.